Parker Bioscience Filtration – a leader in motion and control technologies – has expanded manufacturing capabilities via a recent investment at its Birtley, UK site and is helping to support vaccine production in EMEA.   Expanding Capacity   Following a substantial development of its manufacturing facilities at Birtley, Parker Bioscience Filtration is now meeting increased demand for specialist single-use manifolds from vaccine producers and has the capacity to further increase its current manif...